Unlock instant, AI-driven research and patent intelligence for your innovation.

High speed sample workflow for lc-ms based hba1c measurement

A sample, whole blood sample technology, applied in the field of clinical diagnostic systems, can solve the problems of time-consuming, limited high-throughput measurement of patient samples, etc.

Pending Publication Date: 2021-08-24
F HOFFMANN LA ROCHE & CO AG
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, these methods are time-consuming and of limited utility for high-throughput measurements of patient samples

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • High speed sample workflow for lc-ms based hba1c measurement
  • High speed sample workflow for lc-ms based hba1c measurement
  • High speed sample workflow for lc-ms based hba1c measurement

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0059] A first aspect of the present invention relates to a method for determining glycated hemoglobin A (HbA1c) in a sample, comprising:

[0060] (a) providing a sample comprising hemoglobin A (HbA) molecules,

[0061] (b) subjecting the sample from step (a) to a partial proteolytic digestion step in which an N-terminal fragment of the hemoglobin Aβ chain molecule is produced,

[0062] (c) optionally enriching the N-terminal fragment of the hemoglobin Aβ chain molecule produced in step (b), and

[0063] (d) Analysis of the sample comprising the N-terminal fragment of the hemoglobin Aβ chain molecule by mass spectrometry (MS), wherein the amount or concentration of HbA1c in the sample is determined.

[0064]Thus, the amount or concentration of HbA1c in a sample can be determined, in particular the relative amount of HbA1c, ie the ratio of glycated HbA1c molecules to non-glycated HbA0 molecules or to the total number of HbA molecules. When repeatedly determining the amount of...

example 1

[0186] Determination of HbA1 Peptide Fragments in Whole Blood

[0187] Dilute 100 μL of whole blood sample with 900 μL HO 2 O diluted and vortexed for 10 s until a clear solution was obtained. Then, further dilute 5 µL of the hemolyzed whole blood sample with 20 µL of HO. 5 μL of diluted hemolyzed blood sample, 15 μL intracellular protease Glu-C (2 mg / mL) and 30 μL digestion buffer (50 mM ammonium acetate pH 4.3) were added to LoBind vials (Eppendorf) and incubated at 37°C for 45 min to provide partial digestion, For example 1% to 20% of the HbA molecules present in the sample are digested. The enzymatic reaction was stopped by adding 950 μL of 0.1% (v / v) formic acid.

[0188] Then, provide several batches of 100 μL of hydrophobic magnetic beads (50 mg / mL). Mix 200 μL of digested whole blood sample with 700 μL of HO containing 0.1% (v / v) formic acid 2 O was added to each batch of beads. The mixture was shaken at 37 °C and 1200 rpm for 5 min.

[0189] Next, the beads wer...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
pore sizeaaaaaaaaaa
Login to View More

Abstract

The present invention refers to a method for determining peptide fragments of glycated hemoglobin A (HbA1c) molecules by mass spectrometry (MS), a reagent kit, and a clinical diagnostic system adapted for performing the method.

Description

technical field [0001] The present invention relates to a method, a kit and a clinical diagnostic system suitable for performing the method for the determination of peptide fragments of the glycated hemoglobin A (HbA1c) molecule by mass spectrometry (MS). Background technique [0002] Impaired control of circulating blood glucose levels is an indicator of diabetes. Glucose can be attached to lysine residues of polypeptides in a non-enzymatic statistical process, resulting in glycated polypeptides. In the case of hemoglobin A (HbA), glucose reacts with the N-terminus of the beta chain. The resulting glycated hemoglobin Aβ chain was designated as HbA1c. [0003] HbA1c is the major glycated hemoglobin species in human blood. Evidence from the Comprehensive Diabetes Control and Complications Trial (DCCT) suggests that complications such as retinopathy, nephropathy and neuropathy are directly related to the degree of hyperglycemia in insulin-dependent diabetes mellitus (IDDM) ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/72G01N33/68
CPCG01N33/6848G01N33/723
Inventor U·科博尔德A·莱嫩巴赫I·米特拉
Owner F HOFFMANN LA ROCHE & CO AG